# CYTEK BIOSCIENCES INC (CTKB)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CTKB/

- Reporting holders: 6
- Reported value: $90.2K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Everhart Financial Group, Inc.](https://holderbook.com/funds/1852858-everhart-financial-group-inc/) | $77.3K | 12,962 | 0.0% | 6 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $7.4K | 1,239 | 0.0% | 4 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $2.8K | 473 | 0.0% | 9 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.7K | 448 | 0.0% | 12 |
| [Davis Capital Management](https://holderbook.com/funds/1811806-davis-capital-management/) | $66 | 11 | 0.0% | 2 |
| [GILPIN WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/2058144-gilpin-wealth-management-llc/) | $36 | 6 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 6 | $90.2K |
| Q2 2026 | 157 | $380.9M |
| Q1 2026 | 164 | $373.1M |
| Q4 2025 | 154 | $414.3M |
| Q3 2025 | 151 | $278.6M |
| Q2 2025 | 157 | $271.3M |
| Q1 2025 | 160 | $312.8M |
| Q4 2024 | 152 | $503.7M |
| Q3 2024 | 134 | $420.4M |
| Q2 2024 | 127 | $430.2M |
| Q1 2024 | 122 | $553.9M |
| Q4 2023 | 102 | $730.0M |